"10.1371_journal.pone.0101260","plos one","2014-06-26T00:00:00Z","Raffaella Sabatino; Antonella Antonelli; Serafina Battistelli; Reto Schwendener; Mauro Magnani; Luigia Rossi","Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy; Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland; EryDel SpA, Urbino (PU), Italy","Conceived and designed the experiments: RS MM LR. Performed the experiments: RS AA SB LR. Analyzed the data: RS AA SB RS MM LR. Contributed reagents/materials/analysis tools: RS MM LR. Contributed to the writing of the manuscript: RS LR.","The author has read the journals policy and the authors of this manuscript have the following competing interests: This work was partially supported by EryDel S.p.A. who provided research materials. Mauro Magnani and Luigia Rossi are employed by EryDel S.p.A. and hold shares in the company. Novartis Pharma (Basel, Switzerland) provided Zoledronate for this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","06","Raffaella Sabatino","RS",6,TRUE,3,4,5,NA,TRUE,TRUE,FALSE,0,NA,FALSE
